Sponsored Product Theaters
2022 Non-AAOA Satellite Events
These commercially supported Product Theaters are independent of the American Academy of Otolaryngic Allergy (AAOA) educational activities and are not accredited by AAOA.
Optinose
Friday, September 9, 2022
12.00pm – 1.00pm
Optimizing Topical Treatment of Nasal Polyposis: Role of XHANCE in Stepped Care
Speaker: Naveen Bhandarkar, MD
University of California Irvine Health
Objectives:
- Review challenges in the identification and management of nasal polyposis
- Identify key differentiating features of the Exhalation Delivery System™ (EDS®)
- Review data on efficacy and safety of XHANCE®
- Discuss the treatment algorithm for nasal polyps and role of XHANCE for:
- Patients whose symptoms do not resolve with a standard nasal steroid spray
- Optimizing topical medication management before escalation of care
- Medical management after surgery
You may pre-register via:
Email: OptinoseEvents@premierhealthcare.com Event Code: XHN0003260
______________________________________________________________
GSK
Saturday, September 10, 2022
8.00am – 9.00am
What’s Driving Recurrent Disease in Your Patients?
Targeting Eosinophils With a Biologic as an Option for Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Speakers:
Cecelia Damask, DO
Medical Director
Lake Mary ENT and Allergy, Lake Mary FL
Robert C Kern MD
Chair Department of Otolaryngology – Head and Neck Surgery
Northwestern Medical Chicago IL
Join us for an expert-led panel discussion exploring the clinical features of patients struggling with CRSwNP. We will review the role of eosinophils as a driver of severe, recurrent CRSwNP and discuss practical approaches to identifying patients who may benefit from a targeted biologic treatment. Clinical trial evidence for the use of a biologic that targets eosinophils as a non-surgical treatment option will be covered.
Location: Loews Philadelphia Hotel, Regency Ballroom C
________________________________________________________________
Regeneron and Sanofi
Saturday, September 10, 2022
11.45am – 12.45pm
Explore a Different Path to Control Chronic Rhinosinusitis With Nasal Polyposis in Your Patients With Inadequately Controlled Disease
Speaker:
David Yen, MD
Physician, President, Co-Founder
Specialty Physician Associates
Bethlehem, PA
Objective:
Engage with our presenter as they discuss a treatment option for patients with inadequately controlled chronic rhinosinusitis with nasal polyposis (CRSwNP). They will discuss the underlying Type 2 inflammation that contributes to the disease burden. The presenter will apply these concepts into their case-based review of a patient with CRSwNP.
Location: Loews Philadelphia Hotel, Regency Ballroom C
________________________________________________________________
Amgen and AstraZeneca
Saturday, September 10, 2022
7.00pm – 9.00pm
Tezspire: A Clinical Overview
Speaker: Michael Marcus, MD
Objective:
This presentation will explore the role of TSLP in severe asthma. We will discuss the mechanism of action of Tezspire. In addition, we will review the efficacy and safety profile data of Tezspire from key clinical trials, and understand the potential impact of Tezspire in clinical practice.
Location: Reading Terminal Market – 1136 Arch St, Philadelphia, PA 19107, Door 6
________________________________________________________________
GSK
Sunday, September 11, 2022
8.00am – 9.00am
Misery Loves Company! Unrecognized Impacts on Quality of Life and OCS Burden in Nasal Polyposis
Speaker: Jennifer Villwock, MD, FAAOA
Join our expert who will discuss the unrecognized impacts on quality of life and explore oral corticosteroid (OCS) burden that patients with chronic rhinosinusitis with nasal polyposis (CRSwNP) may experience. Strategies to reduce OCS use will also be discussed.
Location: Loews Philadelphia Hotel, Commonwealth C,D
___________________________________________________________________
Integrity Continuing Education, Inc.
Sunday, September 11, 2022
11.45am – 12.45pm
On the Case: An Expert Panel Challenge for the Management of Difficult Cases of CRSwNP
Speakers:
Joseph K. Han, MD
Professor of Medicine
Chief, Division of Rhinology & Endoscopic
Sinus and Skull Base Surgery
Eastern Virginia Medical School
Norfolk, Virginia
Anju T. Peters, MD
Professor of Medicine
Director of Clinical Research
Division of Allergy/Immunology and Otolaryngology
Northwestern University Feinberg School of Medicine
Chicago, Illinois
Bruce K. Tan, MD
Associate Professor of Medicine
Otolaryngology – Head and Neck Surgery
Northwestern University Feinberg School of Medicine
Chicago, Illinois
Learning Objectives:
- Differentiate between each new and emerging biologic treatment for CRSwNP using data from clinical trials and other analyses
- Incorporate a patient-centric focus into evaluating the physical, extranasal, and psychosocial aspects of disease burden for each CRSwNP patient
- Elucidate best practices criteria for recommending sinus surgery or biologic therapy and when systemic corticosteroids may or may not be appropriate
Location: Loews Philadelphia Hotel, Commonwealth C,D and Whova (please go to Whova platform – Agenda)
These commercially supported Product Theaters are independent of the American Academy of Otolaryngic Allergy (AAOA) educational activities and are not accredited by AAOA.
Become Our Partner
Interested in sponsoring a satellite event? Check out the 2022 AAOA Exhibitor Prospectus or contact AAOA today
2022 ANNUAL MEETING
We would like to thank our 2022 Corporate Sponsors and Exhibitors!
Virtual Exhibit Bag for the 2022 AAOA Annual Meeting Attendees. Submit your insert by September 1st, 2022. See the 2022 Exhibitor Prospectus for more details or contact mfassnacht@aaoallergy.org for more information.
